Literature DB >> 1639791

Genistein inhibits protein histidine kinase.

J Huang1, M Nasr, Y Kim, H R Matthews.   

Abstract

Protein histidine kinase was prepared from whole cell extracts of the yeast, Saccharomyces cerevisiae. The enzyme was assayed using either histone H4 or a synthetic peptide corresponding to residues 70 to 102 of histone H4 as an in vitro substrate. With either substrate, both genistein and its solvent, dimethyl sulfoxide (Me2SO), inhibited protein histidine kinase. Me2SO alone gave a cooperative dose-response curve, with inhibition changing from almost zero below 10% Me2SO to 80% at 20% Me2SO with either substrate. Genistein gave a simple dose-response curve with 50% inhibition of protein histidine kinase at 110 microM genistein. In experiments with protein histidine kinase, genistein was a noncompetitive inhibitor with respect to ATP, histone H4 or the synthetic peptide, although, in the case of the synthetic peptide, the data were also consistent with competitive inhibition. These data gave Km values for both ATP and histone H4 of 15 microM, in satisfactory agreement with previously reported values (Huang, J., Wei, Y., Kim, Y., Osterberg, L., and Matthews, H. R. (1991) J. Biol. Chem. 266, 9023-9031). The Km for the synthetic peptide was 80 microM. The KI values were 270 or 310 microM measured with histone H4 or the synthetic peptide as substrate, respectively. While these KI values are relatively high, relative to published KI values for genistein inhibition of protein tyrosine kinases, many reported experiments use genistein at concentrations where inhibition of protein histidine kinase occurs. It is possible that some of the observed effects of genistein in vivo may be due to inhibition of protein histidine kinase.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639791

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Inhibition of ATPase, GTPase and adenylate kinase activities of the second nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein.

Authors:  C Randak; E A Auerswald; I Assfalg-Machleidt; W W Reenstra; W Machleidt
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Phytochrome-regulated repression of gene expression requires calcium and cGMP.

Authors:  G Neuhaus; C Bowler; K Hiratsuka; H Yamagata; N H Chua
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

Review 3.  Essential Two-Component Systems Regulating Cell Envelope Functions: Opportunities for Novel Antibiotic Therapies.

Authors:  Silvia T Cardona; Matthew Choy; Andrew M Hogan
Journal:  J Membr Biol       Date:  2017-11-02       Impact factor: 1.843

4.  Daidzin and daidzein suppress free-choice ethanol intake by Syrian golden hamsters.

Authors:  W M Keung; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  Regulation of N-acetylglucosaminyltransferase V by protein kinases.

Authors:  T Z Ju; H L Chen; J X Gu; H Qin
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

6.  Genistein inhibits constitutive and inducible NFkappaB activation and decreases IL-8 production by human cystic fibrosis bronchial gland cells.

Authors:  O Tabary; S Escotte; J P Couetil; D Hubert; D Dusser; E Puchelle; J Jacquot
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

7.  Differential regulation of early response genes and cell proliferation through the human granulocyte macrophage colony-stimulating factor receptor: selective activation of the c-fos promoter by genistein.

Authors:  S Watanabe; A Muto; T Yokota; A Miyajima; K Arai
Journal:  Mol Biol Cell       Date:  1993-10       Impact factor: 4.138

8.  Tumour necrosis factor-alpha-induced ICAM-1 expression in human vascular endothelial and lung epithelial cells: modulation by tyrosine kinase inhibitors.

Authors:  A Burke-Gaffney; P G Hellewell
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

9.  Inhibition of development of Myxococcus xanthus by eukaryotic protein kinase inhibitors.

Authors:  R Jain; S Inouye
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

Review 10.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.